BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2968523)

  • 1. A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.
    Moran E
    Nature; 1988 Jul; 334(6178):168-70. PubMed ID: 2968523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional similarity between HPV16E7, SV40 large T and adenovirus E1a proteins.
    Vousden KH; Jat PS
    Oncogene; 1989 Feb; 4(2):153-8. PubMed ID: 2538790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separation of immortalization and T24-ras oncogene cooperative functions of adenovirus E1a.
    Kuppuswamy M; Subramanian T; Chinnadurai G
    Oncogene; 1988 Jun; 2(6):613-5. PubMed ID: 2968534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of c-myc in the transformation of REF52 cells by viral and cellular oncogenes.
    Kohl NE; Ruley HE
    Oncogene; 1987; 2(1):41-8. PubMed ID: 2830582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of the C-terminal region of adenovirus E1a for cell transformation in cooperation with E1b.
    Subramanian T; Malstrom SE; Chinnadurai G
    Oncogene; 1991 Jul; 6(7):1171-3. PubMed ID: 1830644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence homology of Epstein-Barr virus nuclear antigen-2 to adenovirus E1A, human papilloma virus-16 E7 and SV40 large T antigen in the functional domains for growth transformation.
    Harada S; Yanagi K
    Oncogene; 1991 Mar; 6(3):461-2. PubMed ID: 1849247
    [No Abstract]   [Full Text] [Related]  

  • 8. Biological and biochemical activity of E7 genes of the cutaneous human papillomavirus type 5 and 8.
    Yamashita T; Segawa K; Fujinaga Y; Nishikawa T; Fujinaga K
    Oncogene; 1993 Sep; 8(9):2433-41. PubMed ID: 8395681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converting the JCV T antigen Rb binding domain to that of SV40 does not alter JCV's limited transforming activity but does eliminate viral viability.
    Tavis JE; Trowbridge PW; Frisque RJ
    Virology; 1994 Mar; 199(2):384-92. PubMed ID: 8122368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chaperone function of the SV40 large T antigen.
    Pipas JM
    Dev Biol Stand; 1998; 94():313-9. PubMed ID: 9776252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein.
    Caruso M; Martelli F; Giordano A; Felsani A
    Oncogene; 1993 Feb; 8(2):267-78. PubMed ID: 8381218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co-activator, p300.
    Avantaggiati ML; Carbone M; Graessmann A; Nakatani Y; Howard B; Levine AS
    EMBO J; 1996 May; 15(9):2236-48. PubMed ID: 8641289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An N-terminal region of adenovirus E1a essential for cell transformation and induction of an epithelial cell growth factor.
    Subramanian T; Kuppuswamy M; Nasr RJ; Chinnadurai G
    Oncogene; 1988 Feb; 2(2):105-12. PubMed ID: 2966920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E1A deregulates the centrosome cycle in a Ran GTPase-dependent manner.
    De Luca A; Mangiacasale R; Severino A; Malquori L; Baldi A; Palena A; Mileo AM; Lavia P; Paggi MG
    Cancer Res; 2003 Mar; 63(6):1430-7. PubMed ID: 12649209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of the neu promoter by the SV40 large T antigen.
    Matin A; Hung MC
    Cell Growth Differ; 1993 Dec; 4(12):1051-6. PubMed ID: 7906953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXXC Zn binding motifs of the human papillomavirus type 16 E7 oncoprotein are not required for its in vitro transforming activity in rodent cells.
    Braspenning J; Marchini A; Albarani V; Levy L; Ciccolini F; Cremonesi C; Ralston R; Gissmann L; Tommasino M
    Oncogene; 1998 Feb; 16(8):1085-9. PubMed ID: 9519882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic functions of mutant polyomavirus large T-antigen with deletion of retinoblastoma protein-binding motif.
    Söderbärg K; Magnusson G
    Virology; 1993 Mar; 193(1):281-8. PubMed ID: 8382398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutants with changes in conserved region II: three classes with differing antibody reactivity, SV40 T antigen binding and ability to inhibit transformation of rat cells.
    Schmieg FI; Simmons DT
    Oncogene; 1993 Aug; 8(8):2043-50. PubMed ID: 8393158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell type dependent transformation by adenovirus 5 E1a proteins.
    Kuppuswamy M; Chinnadurai G
    Oncogene; 1988 Jun; 2(6):567-72. PubMed ID: 2968533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of HPV18 and BPV1 transcription in human keratinocytes by simian virus 40 large T antigen and adenovirus type 5 E1A antigen.
    Bernard BA; Bailly C; Lenoir MC; Darmon MY
    J Cell Biochem; 1990 Feb; 42(2):101-10. PubMed ID: 2155243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.